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Objective: A surgical strategy for treating malignant renal tumors with thrombus extending into the inferior vena cava
(IVC) was assessed.
Methods: We retrospectively reviewed the records for all patients with renal cell carcinoma (RCC; n 30) or Wilms tumor
(n  1) with tumor thrombus extending into the IVC who underwent surgical intervention at our institution between
January 1980 and December 2001. Tumors were classified preoperatively according to the cephalad extension of
thrombus, and intraoperative procedures were selected on the basis of degree of extension. Patients with RCC underwent
radical nephrectomy and removal of thrombus with (n  11) or without (n  19) IVC resection. Partial normothermic
cardiopulmonary bypass without cardiac arrest was used in 4 patients. The Pringle maneuver was performed in 8 patients.
Infrarenal abdominal aortic cross-clamping was used in 8 patients to maintain systemic blood pressure. IVC cross-
clamping and the Pringle maneuver were performed in 5 patients with suprahepatic thrombus extension. Temporary
placement of a filter in the IVC or plication of the IVC above the hepatic vein was performed before hepatic mobilization,
to decrease the risk for pulmonary embolism.
Results: One patient died intraoperatively of pulmonary embolism. Postoperative complications occurred in 11 patients;
all resolved with conservative therapy. The postoperative duration of survival in patients with RCC was 37 44 months
(range, 4-180 months); the 5-year survival rate was 42%.
Conclusion: Aortic cross-clamping during IVC occlusion prevented hypotension and maintained hemodynamic stability
that has required bypass in other series. This surgical treatment with the less extensive approach could result in long-term
survival of patients with RCC in whom tumor thrombus extends into the IVC. We recommend that radical nephrectomy
and tumor thrombectomy, with or without caval resection, be performed in these patients, with less invasive additional
maneuvers. (J Vasc Surg 2004;39:829-35.)The most common type of tumor occupying or extend-
ing into the inferior vena cava (IVC) is renal cell carcinoma
(RCC), and such extension has been observed in 4% to 19%
of RCCs.1-8 Tumor thrombectomy in the IVC improved
the prognosis in patients with this condition, including
those in whom tumor thrombus extends far into the ves-
sel.6,9 In contrast, if only nephrectomy is performed the
prognosis is poor and almost all patients die within a year.10
With the advances in immunotherapy with such agents as
interferon,11 control of distant metastases in patients with
RCC extending into the IVC can be achieved; thus survival
of these patients may increase if aggressive surgery includ-
ing tumor thrombectomy is combined with immunother-
apy. It appears worthwhile to perform thrombectomy even
in patients in whom RCC thrombus extends to the level of
the right atrium. We reviewed the records for patients in
whom this surgical strategy was used, and assessed its effect
on survival.
From the Departments of Surgery,a Urology,b and Thoracic Cardiovascular
Surgery,c Tokyo Medical and Dental University Graduate School.
Competition of interest: none.
Reprint requests: Masatoshi Jibiki, MD, PhD, Tokyo Medical and Dental
University, Department of Surgery, 1-5-45 Yushima, Bunkyo-ku, Tokyo
113-8519, Japan (e-mail: jibiki.srg1@tmd.ac.jp).
0741-5214/$30.00
Copyright © 2004 by The Society for Vascular Surgery.
doi:10.1016/j.jvs.2003.12.004PATIENTS AND METHODS
We retrospectively reviewed the records for 30 patients
with RCC and 1 patient with Wilms tumor with tumor
thrombus extending into the IVC who were treated surgi-
cally at our institution between January 1980 and Decem-
ber 2001. Twenty-two patients were men, and 9 patients
were women; their mean age ( SD) age was 63 10 years
(range, 23-77 years). Twenty-one patients had stage III
disease and 10 had stage IV disease, according to the
tumor-node-metastasis classification system. Nine patients
were found preoperatively to have distant metastases (Ta-
ble). Before surgery, tumors were classified into four cate-
gories according to the level of cephalad extension of tumor
thrombus into the IVC, as described by Naves and
Zincke12 (Fig 1). The extension level was determined by
using abdominal computed tomography (CT), magnetic
resonance imaging (MRI), cavography, and duplex scan-
ning. Tumor thrombus extended from the renal vein into
the infrahepatic segment of the IVC, less than 2 cm from
the renal vein, in 13 patients (level I); to below the hepatic
vein in 9 patients (level II); into the suprahepatic segment
of the IVC but not into the atrium in 5 patients (level III);
and into the atrium in 4 patients (level IV).
Three patients had leg edema, and RCC extending into
the IVC was confirmed in two of these patients. In the third829
ient d
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months and tumor extending into the IVC was not initially
found; the patient had been admitted because of another
problem. Leg edema was present in only 2 patients admit-
ted because of RCC extending into the IVC, probably
because the other patients had adequate collateral draining
veins.
During the surgical procedure duplex scanning and
transesophageal echocardiography were performed to re-
confirm the cephalad extension of tumor thrombus and to
evaluate cardiac function. Selection of specific surgical tech-
niques and additional measures was made on the basis of
thrombus extension level and the degree of IVC patency.
The IVC was occluded in 13 patients, and was patent in 18
patients. Caval tumor thrombectomy and closure of the
longitudinal caval incision were performed in 17 patients
with a patent IVC, with preservation of the contralateral
renal vein, and in 2 patients with an occluded IVC. The
other 11 patients with an occluded IVC underwent IVC
resection. No IVC reconstructions were performed in this
series.
In patients with an occluded IVC, either renal vein
ligation or reconstruction was performed, depending on
the disease site. If RCC originating from the right kidney
extended into the IVC, the left renal vein (LRV) was
separated from the IVC because the LRV had several
branch veins (adrenal, ovarian, lumbar) draining into the
hemiazygos system. On the other hand, if RCC from the
left kidney extended into the IVC, the connection between
the right renal vein (RRV) and caudal IVC should be
preserved, or the RRV should be reconstructed to the
caudal IVC because of a paucity of draining veins from the
right kidney.
Calligaro et al13 reported that the LRV could be di-
vided if its stump pressure was about 50 to 60 cm of water
(37-44 mm Hg) or lower. Higher backpressure suggests
insufficient drainage into the branch veins (adrenal, ovar-
ian, lumbar) and possible risk for renal congestion or renal
rupture from high venous pressure. In aortic repair, when
the backpressure is greater than 40 mm Hg, reconstruction
with an expanded polytetrafluoroethylene graft or direct
anastomosis is required. Thus, in our series, stump pressure
Findings in 31 patients with renal carcinoma, according to
inferior vena cava
Finding
Level I
(n  13)
Distant metastasis (no. of cases) Lung (3), orbit (1)
Operating time (min; mean  SD) 284  82
Blood loss (mL; mean  SD) 1313  699
Complications (no. of cases) ARF (2), ileus (3),
cholecystitis (1)
ARF, Acute renal failure; DVT, deep-vein thrombosis; DIC, disseminated i
*For operating time and blood loss, n  7, because hepatectomy was perfo
another patient, and the data for the two patients were excluded.
†For operating time, blood loss, and complications, n  4, because one patof 40 mm Hg was assumed to indicate that ligation was
feasible, if renal function was satisfactory.
In patients with level III tumor thrombus extension the
supradiaphragmatic segment of the IVC was clamped after
the pericardium was incised. Measures used to prevent
pulmonary embolism were temporary placement (the day
before surgery) of an IVC filter and plication of the IVC by
inserting 3-0 polypropylene sutures in its suprahepatic or
retrohepatic segment. In the 4 patients with level IV tumor
thrombus, partial normothermic cardiopulmonary bypass
(CPB), without cardiac arrest, and cannulation of the fem-
oral artery and vein and the superior vena cava were per-
formed.
Partial or total abdominal aortic cross-clamping, with-
out administration of heparin, was necessary in 8 patients
with a patent IVC, because systemic blood pressure fell
below 80 mm Hg during IVC cross-clamping, as a result of
decreased venous return. Systemic blood pressure could be
maintained at greater than 100 mm Hg by using this
method, without CPB. The Pringle maneuver14 was ap-
plied to prevent bleeding from the hepatic vein and hepatic
congestion in 4 patients in whom suprahepatic IVC clamp-
ing was used and 4 patients who underwent partial CPB.
For the data analysis, the duration of cross-clamping of
the abdominal aorta and clamping of the portal vein and
hepatic artery, the operating time, the amount of blood lost
during surgery, and the postoperative survival duration are
expressed as mean  SD. Survival curves were calculated
with the Kaplan-Meier product-limit method. Survival dif-
ferences between groups were evaluated with the log-rank
test. P  .05 was considered to represent statistical signifi-
cance.
RESULTS
Overall, mean cross-clamping duration was 23  12
minutes (range, 6-45 minutes). Mean duration of clamping
of the portal vein and hepatic artery with the Pringle
maneuver was 15  1 minutes. The abdominal aorta and
IVC were clamped simultaneously if the systemic blood
pressure fell below 80 mm Hg. After tumor resection and
running suture of the IVC were accomplished, the cross-
clamps on the aorta and IVC were released simultaneously.
alad extension (level) of tumor thrombus into the
Level II
(n  9*)
Level III
(n  5†)
Level IV
(n  4)
g (2), liver (1) Right tibia (1) Left adrenal gland (1)
1  66 457  124 609  52
1  1979 3900  2314 7810  4483
s (2), DVT
2)
None DIC (1)
scular coagulopathy.
because of liver metastasis in one patient, and hepatocelluler carcinoma in
ied during surgery.ceph
Lun
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(
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with the level of thrombus extension (Table. One patient
died intraoperatively of pulmonary embolism. One patient
with RCC on the left side underwent RRV replacement
with an expandable polytetrafluoroethylene graft to pre-
serve the venous flow to the IVC through the RRV. Eleven
patients had postoperative complications (Table), most
commonly, ileus (n  5). All complications resolved with
conservative treatment.
Among the 30 patients with RCC who survived sur-
gery, the postoperative survival duration was 37  44
months (range, 4-180 months). The overall 5-year survival
rate was 42%. Five-year survival rates for patients with levels
I, II, III, and IV thrombus extension were 44%, 53%, 33%,
and 25%, respectively (not significant). Five-year survival
rates for patients with stages III and IV disease were 49%
and 20%, respectively (not significant). The 5-year survival
rate for the 18 patients who had renal capsular invasion was
48%, whereas that for the 11 patients without renal capsular
invasion was 37% (not significant).
A representative case of level II RCC thrombus exten-
sion is shown in Figs 2 to 4. Preoperative abdominal CT
scans revealed a large thrombus extending into the IVC
(Fig 2, top); cavography showed the thrombus extending to
just below the hepatic veins (Fig 2, bottom). During surgery,
suprahepatic IVC cross-clamping and the Pringle maneuver
were performed at the same time. The systemic blood
pressure fell below 80 mm Hg during IVC cross-clamping,
because of decreased venous return, but was raised to more
than 100 mm Hg with partial or total abdominal aortic
cross-clamping, without venovenous bypass or CPB (Fig
3). Tumor thrombectomy was accomplished, and the lon-
gitudinal caval incision was closed with running sutures
because the IVC was not totally obstructed (Fig 4).
DISCUSSION
Berg15 was the first to report nephrectomy and
cavotomy to treat RCC with tumor thrombus extending
into the IVC. Since then, aggressive surgical treatment,
including tumor thrombectomy, has improved the progno-
sis in patients with this serious condition, and it is now used
at many institutions.4,6,9
Fig 1. Extension of renal tumor thrombus into the inferior vena
cava.In our series, tumor thrombus in the IVC was assessed
without difficulty preoperatively with ultrasonography, ab-
dominal CT, MRI, and cavography. The cephalad exten-
sion of thrombus into the vessel was confirmed with either
cavography or MRI, but MRI is preferred because of its
relative noninvasiveness.16 The selection of operative pro-
cedures was made on the basis of the level of thrombus
extension and whether the IVC was patent.
Systemic blood pressure and circulatory status were
stably maintained during cross-clamping of the IVC in
patients in whom the vessel was completely occluded by
thrombus, and the IVC was resected without difficulty.
Although Tsuji et al17 suggested that total clamping of the
IVC below the orifice of the hepatic veins does not induce
hypotension or intestinal congestion, systemic blood pres-
sure fell to less than 80 mm Hg at cross-clamping in 8 of the
18 patients with a patent IVC in our series, because of a
Fig 2. Top, Abdominal CT scan in a 58-year-old man with renal
cell carcinoma (open arrow) shows a large tumor thrombus extend-
ing into the inferior vena cava (black arrow). Bottom, Cavogram in
this patient showed a large tumor thrombus extending into the
inferior vena cava to just below the hepatic veins (arrow). RA,
Right atrium; SHV, short hepatic vein; Rt RV, right renal vein.
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hemodynamic stability was restored by creating a veno-
venous bypass from the common femoral vein to the axil-
lary vein, thereby maintaining venous return.18-20 In our
series, hemodynamic stability was obtained with partial or
total cross-clamping of the infrarenal or supraceliac seg-
ment of the abdominal aorta; this maintained systemic
blood pressure above 100 mm Hg without any adjunctive
procedures, such as venovenous bypass or CPB. This ma-
neuver was based on the method used by Khaneja et al21 to
Fig 3. Intraoperative photograph and diagram in the sam
after partial abdominal aortic cross-clamping was perform
the Pringle maneuver. A, site of suprahepatic IVC cross-c
vein clamping; D, site of infrarenal IVC cross-clamping;
hidden by the surgeon’s hand.control hemodynamic circulation and minimize blood loss,
and decreases in blood pressure by cross-clamping the
supraceliac segment of the aorta in patients with penetrat-
ing injuries of the IVC. Thus, after the infrarenal segment
of the abdominal aorta was exposed and encircled with a
vessel loop, we cross-clamped (test clamping) the IVC and
both renal veins. Blood pressure was then observed for
about 5 minutes. If systemic blood pressure decreased to
less than 80 mm Hg, the infrarenal segment of the abdom-
inal aorta was partly cross-clamped. If blood pressure could
ient as in Fig 2. The inferior vena cava (IVC) was incised
ultaneously with suprahepatic IVC cross-clamping and
ing; B, site of the Pringle maneuver; C, site of right renal
site of partial abdominal aortic cross-clamping, which ise pat
ed sim
lamp
star,
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segment of the aorta was cross-clamped. Supraceliac cross-
clamping should not be continued for more than 30 min-
utes, because longer clamp time may result in renal dys-
function in one kidney.
Interventions that use venovenous bypass to maintain
venous return18-20 are complicated and time-consuming.
Aortic cross-clamping is simpler, more convenient, and
more effective in stabilizing systemic circulation. With this
technique Cummings et al22 performed nephrectomy,
cavotomy, and tumor thrombectomy in patients with RCC
with thrombus extending into the intrapericardial segment
of the IVC. When vascular isolation of the IVC from the
Fig 4. Intraoperative photograph and diagram in the
performed, and the longitudinal caval incision was closed
IVC, inferior vena cava.right atrium to the pelvis was achieved with temporary
circulatory arrest in the lower torso, the circulating blood
volume was divided and blood pressure was maintained.
In patients with tumor thrombus extending into the
suprahepatic segment of the IVC, clamping of the supradi-
aphragmatic segment after only longitudinal diaphragm
and pericardial incision was necessary in this series, whereas
steronotomy and partial CPB was performed by Tsuji et
al.17 The CPB procedure increased operating time and
blood loss in patients with level III and level IV thrombus
(Table). Ideally, CPB should be performed only in patients
with level IV thrombus. In our series, partial normothermic
CPB without cardiac arrest was instituted in patients with
patient as in Figs 2 and 3. Tumor thrombectomy was
running sutures. GB, Gallbladder; Lt RV, left renal vein;same
with
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superior vena cava were cannulated. Tsuji et al17 com-
mented that partial normothermic CPB without cardiac
arrest was used to enable tumor thrombectomy even in
patients in whom thrombus did not extend into the right
atrium. Others have used CPB with cardiac arrest and deep
hypothermia in patients with level IV thrombus.6,9,23-25
However, these procedures were not required in our pa-
tients, because we had no problems with aortic cross-
clamping and the Pringle maneuver, which minimizes
bleeding from the hepatic vein and prevents hepatic con-
gestion, because the location and numbers of short hepatic
veins could not be evaluated and the draining veins could
not be confirmed before the operation. Intestinal conges-
tion can be prevented by clamping the superior mesenteric
artery.
In our patients tumor thrombus could be peeled off the
IVC wall easily, and direct inspection confirmed the ab-
sence of residual tumor in the vein. In some patients with
levels II, III, or IV disease with a patent IVC, exfoliation of
the tumor near the renal vein may be so difficult that both
tumor thrombectomy and wedge resection of the IVC
should be performed, to completely resect tumor that has
apparently invaded the IVC wall around the renal vein
orifice. Radical nephrectomy and excision of tumor extend-
ing into the IVC, with IVC resection, are advisable in
patients in whom the IVC is occluded by tumor thrombus.
In our series, only 2 patients in whom the stump of the IVC
was left had recurrence of tumor during long-term follow-
up. Thus our experience indicates that tumor thrombec-
tomy without IVC resection yields acceptable results in
patients with a patent IVC.
In the series of Tsuji et al17 venous reconstruction was
done in all patients to prevent venous insufficiency. In our
series no IVC reconstructions were performed, and no
serious postoperative complications occurred. IVC recon-
struction was not required, because collateral veins were
sufficiently developed to drain the venous return from the
lower extremities and pelvic region.
In 1 patient in our series a pulmonary embolus devel-
oped suddenly while the liver was mobilized. CPB could
not be used, and the patient died of a massive pulmonary
embolus. Therefore careful skeletonization is important;
furthermore, plication should be performed initially in pa-
tients with level II or III disease, and in patients with level
II disease a filter can be placed into the IVC temporarily.
CPB can be used immediately to enable tumor thrombus
extending into the intrapericardial portion of the IVC to be
mobilized to a more caudal site, and the IVC cross-clamped
at that site, because plication can be difficult in some
patients with level III disease.
The overall 5-year survival rate in our series was 42%,
compared with 34% in the series of Nesbitt et al.6 Our
survival rate was higher, probably because only 1 of our
patients had lymph node metastasis. However, immuno-
therapy with agents such as interferon has improved the
prognosis in advanced RCC with tumor thrombus in the
IVC. Thus an aggressive surgical approach is warranted.With both surgical treatment and adjuvant immunother-
apy, the 5-year survival rate in patients with liver or bone
metastasis, or both, was 17%; in patients with liver or lung
metastasis the rate was 43%.11 Lung metastasis had no
adverse effect on survival after surgery.11 Nephrectomy,
tumor thrombectomy, and hepatectomy might be indi-
cated in patients at relatively low-risk with liver metastasis,
even though the long-term survival rate in these patients is
lower than in patients with lung metastasis, and lymph
node metastasis is generally the most important prognostic
factor.6
In conclusion, selection of the surgical strategy for
treatment of RCC with thrombus extending into the IVC
should be made on the basis of the level of extension,
patency of the IVC, and laterality of the carcinoma. Blood
pressure and hemodynamic stability were maintained intra-
operatively with partial or total aortic cross-clamping. Par-
tial normothermic CPB without cardiac arrest should be
performed in patients with level IV disease. The Pringle
maneuver should be applied to minimize blood loss from
the hepatic vein and prevent hepatic congestion when CPB
is used or the suprahepatic portion of the IVC is clamped. It
is desirable to use temporary placement of an IVC filter and
plication of the IVC in its suprahepatic or retrohepatic
segment to prevent pulmonary embolism. The relatively
satisfactory postoperative survival duration and survival rate
achieved in our series indicate that nephrectomy and caval
tumor thrombectomy, with or without cavotomy, should
be used aggressively, with a less extensive approach and less
invasive additional maneuvers in patients with RCC with
thrombus extending into the IVC.
We thank Kae Yoshizawa for assistance with prepara-
tion of the manuscript.
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